Cool heads: The impact of coronavirus

Lynda Zhou, Judith Finegold and Amit Lodha on the impact of the coronavirus

Video - 7 min watch

In this edition of Cool Heads, our China portfolio manager Lynda Zhou describes the local impact of the coronavirus: she normally works in Shanghai but is self-quarantining in Hong Kong.

Healthcare analyst and portfolio manager Judith Finegold and global portfolio manager Amit Lodha discuss the nature of the virus and how the outbreak is affecting companies and markets around the world. They consider how far and fast the disease may have spread and the implications for investor portfolios. 

“There hasn't been the overreaction in the market that would make us change our portfolios at this stage."

- Amit Lodha, Portfolio Manager, Global Equities

Article - 2 min read

A new decade brings with it a new disease. The novel coronavirus has spread quickly from its origins in central China, infecting tens of thousands of people and triggering city-wide shutdowns and quarantine measures.

Markets respond to liquidity injection
Markets initially sold off in response to the outbreak, with sectors such as airlines, tourism and commodities among the hardest hit when the Lunar New Year holiday ended. But the Chinese market has since partially rebounded thanks to swift, preemptive government action: a 10-basis point repo rate cut and an additional liquidity injection of 500 billion yuan ($71bn), on top of 1.2 trillion ($170bn) that the authorities made available on Monday.

Sectors such as online companies have actually benefited as more people stay at home. Smaller companies working on vaccines have seen their prices treble, despite the fact it can take six to 12 months to produce a viable product. Government bond prices, meanwhile, have risen in a perceived flight to safety and amid more accommodative monetary policy.

Onshore China investors remain more nervous than offshore, as they are feeling a more immediate impact, monitoring daily infection reports and coping with travel restrictions. Small and medium-sized companies in the country are finding it easier to borrow from local banks - to keep paying staff and bills - thanks to government intervention, but we expect more targeted tax cuts and stimulus to follow.

Limited comparison with SARS
It remains hard to assess the longer-term impact on China and the global economy. The most obvious comparison is with the SARS virus in 2003, but that has limitations. First, the number of infected people is far higher than during the SARS outbreak, while the mortality rate so far appears to be lower.

Second, the SARS virus quickly made people feel unwell, prompting them to seek help. People with the coronavirus can often be asymptomatic for up to five days, allowing them to infect others unintentionally. Finally, SARS disappeared as soon as the weather improved, but it is too soon to tell if that will happen this time.

So far, global markets appear to believe new cases of infection will decline, and even that this outbreak will be shorter-lived than SARS thanks to government measures; though there will be an impact on Q1 GDP growth. However, it is possible that the spread is far wider than has been reported. Last year, around 160m Chinese travelled while it was closer to 20-30m prior to the SARS outbreak. Trade between China and Africa has also increased dramatically since SARS, meaning there could well be cases on that continent that have yet to be identified due to a lack of diagnostic kits.

Impact on earnings
While we believe there could be an impact on global earnings from lost business activity in China due to the virus, there has been no significant overreaction in global markets that would prompt a big change in our portfolios at this stage.

 

Watch the video here

 

This webpage is issued by FIL Responsible Entity (Australia) Limited ABN 33 148 059 009, AFSL No. 409340 (“Fidelity Australia”). Fidelity Australia is a member of the FIL Limited group of companies commonly known as Fidelity International.

Prior to making an investment decision retail investors should seek advice from their financial adviser. Please remember past performance is not a guide to the future. You should consider the Product Disclosure Statements (“PDS”) for Fidelity products before making a decision whether to acquire or hold the product. Investors should also obtain and consider the Product Disclosure Statement (“PDS”) for the fund mentioned. The relevant PDS can be obtained by contacting Fidelity Australia on 1800 119 270 or by downloading from our website at www.fidelity.com.au. This webcast or podcast has been prepared without taking into account your objectives, financial situation or needs. You should consider such matters before acting on the information contained in this webpage including any linked webcasts or podcasts. This webcast or podcast may include general commentary on market activity, industry or sector trends or other broad based economic or political conditions which should not be construed as investment advice. Information stated herein about specific securities is subject to change. Any reference to specific securities should not be construed as a recommendation to buy, sell or hold these securities. While the information contained in this webcast or podcast has been prepared with reasonable care no responsibility or liability is accepted for any errors or omissions or misstatements however caused. References to ($) are in Australian dollars unless stated otherwise. Investments in overseas markets can be affected by currency exchange and this may affect the value of your investment. Investments in small and emerging markets can be more volatile than other more developed markets. Fund references are correct at time of first publication but are subject to change and may not represent actual holdings in the fund at the time of this viewing. The webcast or podcast may not be reproduced or transmitted without prior written permission of Fidelity Australia. The issuer of Fidelity funds is FIL Responsible Entity (Australia) Limited ABN 33 148 059 009, AFSL No. 409340 (“Fidelity Australia”). 

© 2019 FIL Responsible Entity (Australia) Limited. Fidelity, Fidelity International, and the Fidelity International logo and F symbol, are trademarks of FIL Limited.

Share:
 

Ready to invest in the Fidelity Global Equities Fund?

Discover now
 

Want more insights like this?

Get our free, monthly e-newsletter bringing you valuable insights, opinion and education.

Subscribe